Journal List > Pediatr Infect Vaccine > v.22(2) > 1096006

Kim, Lee, Lee, and Kim: Establishment and Application of a Multibead Serotyping Assay for Pneumococci in Korea

Abstract

Purpose

Serotyping pneumococcal isolates is important to monitor efficacy of pneumococcal vaccines. Because of difficulties of typing pnueumocci, a multiplex bead-based (multibead) serotyping assay was recently introduced. The aim of this study is to establish a new multibead serotyping assay and to apply this method to analyze clinical isolates of pneumococci in Korea.

Methods

To establish the multibead serotyping assay, six key reagents were transferred from University of Alabama at Birmingham (UAB) to Ewha Center for Vaccine Evaluation and Study (ECVES): bead set coated with polysaccharide and monoclonal antibody pool were used in one multiplex inhibition—type immunoassay and 2 bead sets coated DNA probe and 2 primer pools were used in two multiplex PCR—based assays. After multibead serotyping assay was set up, 75 test samples of pneumococci were analyzed whether ECVES is able to identify serotype correctly. After confirming the performance, serotyping assay was applied to identify serotypes of 528 clinical isolates of pneumococci collected from 3 different hospitals.

Results

After establishment of the multibead pneumococcal serotyping assay system at ECVES, 75 test samples were analyzed. There was no discrepancy of serotypes of 75 test samples between the results assigned at UAB and those at ECVES. The serotypes of 528 pneumococci isolated from patients or healthy subjects were determined in 94.3% of isolates (498/528).

Conclusions

The multibead pneumococcal serotyping assay can be successfully established in Korea. With this method, surveillance of serotypes of pneumococci isolated from patients as well as healthy subjects could be studied.

REFERENCES

1. Bentley SD, Aanensen DM, Mavroidi A, Saunders D, Rabbi—nowitsch E, Collins M, et al. Genetic analysis of the capsular biosynthetic locus from all 90 pneumococcal serotypes. PLoS Genet. 2006; 2:e31.
crossref
2. CaliX JJ, Nahm MH. A new pneumococcal serotype, 11E, has a variably inactivated wcjE gene. J Infect Dis. 2010; 202:29–38.
3. Park 1H. Geno KA, Yu J, Oliver MB, Kim KH, Nahm MH. Genetic, biochemical, and serological characterization of a new pneumococcal serotype, 6H, and generation of a pneu—mococcal strain producing three different capsular repeat units. Clin Vaccine Immunol. 2015; 22:313–8.
4. Hicks LA, Harrison LH, Flannery B, Hadler JL, Schaffner W, Craig AS, et al. Incidence of pneumococcal disease due to non—pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vacci—nation, 1998—2004. J Infect Dis. 2007; 196:1346–54.
crossref
5. Lund E. Laboratory diagnosis of pneumococcus infections. Bull World Health Organ. 1960; 23:5–13.
6. Slotved HC, Kaltoft M, Skovsted IC, Kerrn MB, Espersen F. Simple, rapid latex agglutination test for serotyping of pneu—mococci (Pneumotest—Latex). J Clin Microbiol. 2004; 42:2518–22.
crossref
7. Pai R, Gertz RE, Beall B. Sequential multiplex PCR approach for determining capsular serotypes of Streptococcus pneu— monjae isolates. J Clin Microbiol. 2006; 44:124–31.
8. Magomani V, Wolter N, Tempia S, du Plessis M, de Gouveia L, von Gottberg A. Challenges of using molecular serotyping for surveillance of pneumococcal disease. J Clin Microbiol. 2014; 52:3271–6.
crossref
9. Yu J, Lin J, Benjamin WH Jr, Waites KB, Lee CH, Nahm MH. Rapid multiplex assay for serotyping pneumococci with monoclonal and polyclonal antibodies. J Clin Microbiol. 2005; 43:156–62.
crossref
10. Yu J, Lin J, Kim KH, Benjamin WH Jr, Nahm MH. Develop—ment of an automated and multiplexed serotyping assay for Streptococcus pneumoniae. Clin Vaccine Immunol. 2011; 18:1900–7.
crossref
11. Yu j. Carvalho Mda G, Beall B, Nahm MH. A rapid pneu—mococcal serotyping system based on monoclonal antibodies and PCR. J Med Micr0b101. 2008; 57:171–8.
12. Turner P, Turner C, Iankhot A, Phakaudom K, Nosten F, Goldblatt D. Field evaluation of culture plus latex sweep serotyping for detection of multiple pneumococcal serotype colonisation in infants and young children. PLoS One. 2013. 81667933.
crossref
13. Siira L, Kaijalainen T, Lambertsen L, Nahm MH, Toropainen M, Virolainen A. From Quellung t0 multiplex PCR, and back when needed, in pneumococcal serotyping. j Clin Microbiol. 2012; 50:2727–31.
14. Dhoubhadel BG, Yasunami M, Yoshida LM, Thi HAN, Thi THV, Thi TAN, et al. A novel high—throughput method for molecular serotyping and serotype—specific quantification of Streptococcus pneumoniae using a nanofluidic real—time PCR system. J Med Microbiol. 2014; 63:528–39.
15. Findlow H, Laher G, Balmer P, Broughton C, Carrol ED, Borrow R. Competitive inhibition flow analysis assay for the non—culture—based detection and serotyping of pneumococcal capsular polysaccharide. Clin Vaccine Immunol. 2009; 16:222–9.
16. Cho EY, Lee H, Choi EH, Kim Yj, Eun BW, Cho YK, et al. Serotype distribution and antibiotic resistance of Streptococ— cus pneumoniae isolated from invasive infections after optional use of the 7-Valent conjugate vaccine in Korea, 2006—2010. Diagn Microbiol Infect Dis. 2014; 78:481–6.
17. Hathaway LJ, Stutzmann Meier P, Battig P, Aebi S, Muhle-mann K. A homologue of aliB is found in the capsule region of nonencapsulated Streptococcus pneumoniae. J Bacteriol. 2004; 186:3721–9.
18. Nagai K, Shibasaki Y, Hasegawa K, Davies TA, Jacobs MR, Ubukata K, et al. Evaluation of PCR primers to screen for Streptococcus pneumoniae isolates and βlactam resistance, and to detect common macrolide resistance determinants. J Antimicrob Chemother. 2001; 48:915–8.
19. Kawaguchiya M, Urushibara N, Ghosh S, Kuwahara O, Morimoto S, Ito M, et al. Serotype distribution and suscepti—bility to penicillin and erythromycin among noninvasive or colonization isolates of Streptococcus pneumoniae in northern Japan: A cross—sectional study in the pre-PCV7 routine immunization period. Microb Drug Resist. 2014; 20:456–65.
20. Park IH, Pritchard DG, Cartee R, Brandao A, Brandileone MC, Nahm MH. Discovery of a new capsular serotype (6C) within serogroup 6 of Streptococcus pneumoniae. J Clin Microbiol. 2007; 45:1225–33.

Fig. 1.
Scheme of multibead serotyping assay procedure. (A) Multibead serotyping assay using monocional antibodies (Reaction A). In this assay, the bacterial lysates and a mixture of color—coded beads coupled to reference capsular polysaccharides (PSs) are incubated with a mixture of monocional antibodies that bind the immobilized capsular PSs. If a capsular P5 is in the sample, the PS will inhibit the binding of the monoclonal antibody to the corresponding PS—coated bead. The amount of the monoclonal antibody bound to the beads is determined using a fluorescently labeled anti—mouse immunoglobulin secondary antibody. (B) Multibead serotyping assay using wzy PCR (Reaction B and C). The assay is designed to detect pneumococcal serotypes by identifying wzy gene. wzy from a pneumococcal lysate is PCR amplified with a mixture of PCR primers and the resulting PCR product is identified by hybridizing it to luminex beads which are conjugated with a serotype specific probe.
piv-22-97f1.tif
Fig. 2.
Specificity of multibead serotyping assay. (A) Normalized fluorescence signals of the beads coated with pneumococcal polysaccharides obtained with the panel of a test sample by use of the multiplexed inhibition type immunoassay with monoclonal antibodies (Reaction A). The numbers on the X axis represents the numbers assigned to the bead regions in the test. (B and C) Geometric mean signal of the beads coated with probes obtained with the panel of each sample by use of the PCR-based multiplexed assay (Reaction B and C). The numbers on the X axis represents the numbers assigned to the bead regions in the test.
piv-22-97f2.tif
Table 1.
Bead Regions and Serotype Specificity in Reaction A, B and C
Reaction A Reaction B Reaction C
Bead Region Analyte Secificity Bead Region Analyte specificity Bead Region Analyte Specificity
101 1 101 iytA 122 9N/9L
102 2 102 cpsa1 123 28A/28F
103 3 103 7B/7c/40 124 10C/1OF
104 4 104 21 125 11B/11C
105 5 105 33A/33F/37 126 13
106 6A 106 15B/15C 127 24F/24A/24B
107 6B 107 16A 128 12A/12B/12F/44/46
108 6C/6D 108 16F 129 19B/19C
110 7F/7A 109 18A/18B/18C/18F 130 27
111 8 110 23A 131 32F/32A
112 9N 111 23B 132 15A/15F
113 9V/9A 112 25F/25A/38 133 33B/33D
114 10A/39 113 10A/10B 134 31
115 11A/11D/11F 114 43 135 41A/41F
116 11E/11A/11D/11F 115 36 136 29
117 12F 116 48 137 45.
118 118 117 34 138 47A
119 15B/15C 118 35A/35C/42 139 33C
120 17F/17A 119 35F/47F 141 NCC2
121 18C 120 35B 142 NCC2 & NCC3
122 19A 140 6C/6D 143 NCC1
123 19F     144 cpsA2
124 20        
125 22F/22A        
126 23F        
127 33F/33A        

Abbreviation: NCC, null capsule clade.

Table 2.
Serotyping Results Deduced bv Multibead Serotyping Assav 10f 528 Clinical Isolates
Reaction A Reaction B Reaction C
Serotype Number isolates (%) Serotype Number of Isolates (%) Serotype Number of Isolates (%)
1 8(1.5) 16F 4(0.8) 13 9(1.7)
3 25(4.7) 23A 16(3.0) 24F/24A/24R 3(0.6)
4 5(0.9) 25F/25/38 6(1.1) 15A/15F 17(3.2)
5 3 (0.6) 34 17 (3.2) 31 1 (0.2)
6A 36 (6.8) 35B 15 (2.8) NCC1 19 (3.6)
6B 17 (3.2)     NCC2 4 (0.8)
6C/6D 27 (5.1)        
7F/7A 1(0.2)        
8 3(0.6)        
9N 3 (0.6)        
9V/9A 13 (2.5)        
10A/39 3 (0.6)        
11A/D/F 36 (6.8)        
11F/(11A/D/F) 3(0.6)        
12F 3 (0.6)        
14 11(2.1)        
15B/15C 22 (4.2)        
17F/17A 2 (0.4)        
18C 3 (0.6)        
19A 65 (12.3)        
19F 51 (9.7)        
20 5(0.9)        
77F/77A 2(0.4)        
23F 32 (6.1)        
33F/33A 2 (0.4)        
2 serotypes in a sample∗ 6(1.1)        
Sum 381 (73.3) Sum 58(11.0) Sum 52(10.0)
Total 498 (94.3)+

1A, 23F; 14, 19F; 4, 23F; 9V, 19A; 3, 19A; 6A, 19F.

Nontypeable isolates: 30 (5.7). Abbreviations' NCC null Capsule dade

TOOLS
Similar articles